A

Apellis Pharma (APLS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Apellis Pharma (APLS)

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more

  • USD51.00
  • USD52.88
  • USD50.33
  • USD70.00
  • 3.80%
  • 113M
  • 1.10M
  • 5.8B
  • 33.32
  • 30.60%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.